| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| Ciprofloxacin Impurity 21 |
|
369652-34-6 |
詳細(xì)
|
| Ciprofloxacin Impurity 22 |
醋酸奧曲肽雜質(zhì) |
86357-19-9 |
詳細(xì)
|
| Zinc Pyrithione Impurity 1 (2-Pyridinethiol) |
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
詳細(xì)
|
| Zinc Pyrithione Impurity 2 (Pyrithione) |
4-羥基吡啶 |
626-64-2 |
詳細(xì)
|
| Alprazolam Impurity 18 |
|
68412-40-8 |
詳細(xì)
|
| Torasemide Impurity 27 |
西酞普蘭雜質(zhì)D |
144025-14-9 |
詳細(xì)
|
| Torasemide Impurity 28 |
S-(+)-N-TRIFLUOROACETODIDEMETHYLCITALOPRAM |
1217811-50-1 |
詳細(xì)
|
| Diethylstilbestrol |
S-(+)-N-TRIFLUOROACETODESMETHYLCITALOPRAM |
1217697-83-0 |
詳細(xì)
|
| Diethylstilbestrol Impurity 1 |
N-TRIFLUOROACETODIDEMETHYLCITALOPRAM |
1076199-47-7 |
詳細(xì)
|
| Diethylstilbestrol Impurity 2 |
|
64169-57-9 |
詳細(xì)
|
| Diethylstilbestrol Impurity 3 |
|
766508-94-5 |
詳細(xì)
|
| Ciprofloxacin Impurity 23 |
|
6429-68-4 |
詳細(xì)
|
| Piraxostat Impurity 24 |
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-benzyl-1-piperazinyl)-3-quinolinecarboxylic Acid Benzyl Ester |
1391052-64-4 |
詳細(xì)
|
| Piraxostat Impurity 25 |
2-吡啶硫酮 |
2637-34-5 |
詳細(xì)
|
| Piraxostat Impurity 26 |
吡啶硫酮 |
1121-30-8 |
詳細(xì)
|
| Ciprofloxacin Impurity 19 |
槲皮素-3-龍膽二糖苷 |
7431-83-6 |
詳細(xì)
|
| Ciprofloxacin Impurity 20 |
(+)-南燭木樹(shù)脂酚 9'-O-葡萄糖甙 |
87585-32-8 |
詳細(xì)
|
| Ciprofibrate Impurity 4（Ciprofibrate EP Impurity D） |
|
138320-11-3 |
詳細(xì)
|
| Ciprofibrate Impurity 5（Ciprofibrate EP Impurity E） |
|
57011-15-1 |
詳細(xì)
|
| Phentolamine Impurity 9 |
Mebeverine Acid Methyl Ester |
1390154-39-8 |
詳細(xì)
|
| *Resorcinol Impurity 5(benzene-1,3-disulfonic acid) |
去甲基美貝維林醇-D5 |
1329488-46-1 |
詳細(xì)
|
| Cinchocaine Impurity 4 ( Cinchocaine EP Impurity D ) |
美貝維林 鹽酸鹽 |
475203-77-1 |
詳細(xì)
|
| Cinchocaine Impurity 1 ( Cinchocaine EP Impurity A ) |
Avermectin B1a, epi- |
106434-14-4 |
詳細(xì)
|
| Cinchocaine hydrochloride |
2-Fluoro-4-chloro biphenyl |
39224-18-5 |
詳細(xì)
|
| Piraxostat Impurity 19 |
環(huán)丙貝特葡糖苷酸 |
102623-15-4 |
詳細(xì)
|
| Piraxostat Impurity 20 |
環(huán)丙沙星哌嗪基-N4-硫酸鹽 |
105093-21-8 |
詳細(xì)
|
| Piraxostat Impurity 18 |
環(huán)丙貝特雜質(zhì)D |
130232-51-8 |
詳細(xì)
|
| Piraxostat Impurity 17 |
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionate |
52179-28-9 |
詳細(xì)
|
| Piraxostat Impurity 15 |
雙-乙基己氧苯酚甲氧苯基三嗪 |
187393-00-6 |
詳細(xì)
|
| Piraxostat Impurity 14 |
八氘代桂利嗪 |
1185242-27-6 |
詳細(xì)
|
| Piraxostat Impurity 23 |
1-Cyclopropyl-1,4-dihydro-6-benzyloxy-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Benzyl Ester |
1391052-85-9 |
詳細(xì)
|
| Piraxostat Impurity 8 |
辛可卡因EP雜質(zhì)C |
87864-08-2 |
詳細(xì)
|
| Piraxostat Impurity 9 |
二丁卡因雜質(zhì)D |
10222-61-4 |
詳細(xì)
|
| Tryptophan Impurity 21（rac-Tryptophan EP Impurity G Monomer） |
1-[(6-Cyclohexyl-d11-4-methyl-2-oxo-1(2H)-pyridinyl)oxy]-1-deoxy--D-glucopyranuronic Acid |
1279033-13-4 |
詳細(xì)
|
| Desloratadine Impurity 40 |
西拉普利 |
92077-78-6 |
詳細(xì)
|
| Ascorbic Acid Impurity 20 |
西拉普利EP雜質(zhì)A |
106860-19-9 |
詳細(xì)
|
| Piraxostat Impurity 1 |
(1S, 9S)-9-[[(R)-1-Ethoxycarbonyl-3-phenylpropyl] amino]-10-oxo-octahydro-6H-pyridazino [1,2-a][1,2] diazepine-1-carboxylic acid |
106928-09-0 |
詳細(xì)
|
| Piraxostat Impurity 2 |
西拉普利N-亞硝基雜質(zhì)(西拉普利雜質(zhì)2) |
1053740-92-3 |
詳細(xì)
|
| Piraxostat Impurity 3 |
西咪替丁-D3 |
1185237-29-9 |
詳細(xì)
|
| Piraxostat Impurity 5 |
|
1215713-38-4 |
詳細(xì)
|
| Piraxostat Impurity 6 |
N-(2-(二乙基)胺乙基)-2-氯-4-喹啉甲酰胺 |
87864-14-0 |
詳細(xì)
|
| Piraxostat Impurity 7 |
2-羥基喹啉-4-羧酸 |
15733-89-8 |
詳細(xì)
|
| Isepamicin Impurity 5 |
環(huán)吡酮胺 |
29342-05-0 |
詳細(xì)
|
| Isepamicin Impurity 6 |
環(huán)吡酮雜質(zhì)B |
14818-35-0 |
詳細(xì)
|
| Isepamicin Impurity 7 |
環(huán)吡酮相關(guān)物質(zhì)C |
67587-24-0 |
詳細(xì)
|
| Serine Impurity 5 |
N-Deshydroxy Ciclopirox-d11 |
1329835-51-9 |
詳細(xì)
|
| Regorafenib Impurity 83 |
環(huán)吡酮-D11葡糖苷酸 |
79419-54-8 |
詳細(xì)
|
| Cilazapril Impurity 5 |
山崳酸甲酯 |
929-77-1 |
詳細(xì)
|
| Ciclopirox Impurity 4 |
鹽酸利托君 |
23239-51-2 |
詳細(xì)
|
| Ciclopirox Impurity 3(Ciclopirox EP Impurity C ) |
尼布拉明雜質(zhì)2 |
38168-82-0 |
詳細(xì)
|
| Ursodeoxycholic Acid Impurity 23 |
|
18839-90-2 |
詳細(xì)
|
| Atropine Impurity 22 (Atropine sulfate monohydrate EP Impurity H) |
化合物 T31485 |
130-79-0 |
詳細(xì)
|
| Methanesulfonic Acid Impurity 6 |
DIETHYLSTILBESTROL-D3 |
58322-36-4 |
詳細(xì)
|
| Piraxostat Impurity 38 |
L-肌肽鋅 |
107667-60-7 |
詳細(xì)
|
| Piraxostat Impurity 30 |
1H-吡唑并[3,4-B]吡啶-3-甲腈 |
956010-88-1 |
詳細(xì)
|
| Lansoprazole Impurity 65 |
1-O-ACETYL-3,4-BIS-(4-ACETOXYPHENYL)-HEXA-2,4-DIEN-1-OL |
70101-24-5 |
詳細(xì)
|
| Piraxostat Impurity 28 |
奧司他韋雜質(zhì)34 |
347378-74-9 |
詳細(xì)
|
| Piraxostat Impurity 27 |
A-羥基阿普唑侖 |
37115-43-8 |
詳細(xì)
|
| Piraxostat Impurity 22 |
1-環(huán)丙基-7-[[2-[[叔丁氧羰基]氨基]乙基]氨基]-6-氟-1,4-二氫-4-氧代-3-喹啉羧酸 |
105589-00-2 |
詳細(xì)
|
| Piraxostat Impurity 21 |
環(huán)丙沙星 |
103237-52-1 |
詳細(xì)
|
| Diclofenac Impurity 28 |
1-(3,4-dichlorophenyl)-1H-pyrazole-4-carboxylic acid |
138907-86-5 |
詳細(xì)
|
| Anacardic Acid |
1-(3,4-DIFLUOROPHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID |
288252-20-0 |
詳細(xì)
|
| Ginkgolic acid 17:1 |
|
61620-92-6 |
詳細(xì)
|
| Mannose Impurity 14 |
1-(3,4-DIMETHYLPHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID |
1204297-04-0 |
詳細(xì)
|
| Mannose Impurity 15 |
5-氨基-1-(4-溴苯基)-1H-吡唑-4-甲酰胺 |
50427-80-0 |
詳細(xì)
|
| Ginkgolic acid 17:2 |
|
100210-14-8 |
詳細(xì)
|
| Ginkgolide Impurity 7 (Ginkgolide M) |
5-氨基-1-(4-硝基苯基)-1H-吡唑-4-羧酸 |
16459-38-4 |
詳細(xì)
|
| Ginkgolide Impurity 8 (Ginkgolide J) |
|
61457-26-9 |
詳細(xì)
|
| Entacapone Impurity 22 |
ethyl 5-(4-nitrophenyl)-1H-pyrazole-4-carboxylate |
35487-11-7 |
詳細(xì)
|
| Entacapone Impurity 23 |
5-氨基-1-(3-(氟甲基)苯基)-1H-吡唑-4-甲酸乙酯 |
110821-29-9 |
詳細(xì)
|
| Tenofovir Alafenamide fumaric acid（GS-7340-03） |
3-(4-溴苯基)-1-苯基-1H-吡唑-4-羧酸 |
372107-34-1 |
詳細(xì)
|
| TAK438 Impurity 134 |
3-(4-甲氧基-苯基)-1H-吡唑-4-羧酸 |
618383-46-3 |
詳細(xì)
|
| TAK438 Impurity 6 HCl |
|
61620-91-5 |
詳細(xì)
|
| Cholesterol Impurity 19 |
|
1260950-82-0 |
詳細(xì)
|
| Cholesterol Impurity 18 |
1-芐基-3-(4-甲基苯基)-1H-吡唑-4-羧酸 |
956453-12-6 |
詳細(xì)
|
| Cholesterol Impurity 16 |
|
60896-26-6 |
詳細(xì)
|
| Rivastigmine Impurity 52 |
3-(4-三氟甲基-苯基)-1H-吡唑-4-甲酸 |
618383-45-2 |
詳細(xì)
|
| Brivaracetam Impurity 58 |
1,3-DIMETHYL-5-[3-(TRIFLUOROMETHYL)PHENOXY]-1H-PYRAZOLE-4-CARBOXYLIC ACID |
446276-23-9 |
詳細(xì)
|
| Brivaracetam Impurity 94 |
1-(3,5-二氟苯基)-5-(1H-吡咯-1-基)-1H-吡唑-4-羧酸 |
1232803-45-0 |
詳細(xì)
|
| Voriconazole Impurity 77 |
1-(氧雜環(huán)丁烷-3-基)-1H-吡唑-4-羧酸 |
1389323-51-6 |
詳細(xì)
|
| Adenosine Impurity 1（Adenosine EP Impurity A）（Adenine） |
1-甲基-5-苯基-1H-吡唑-4-羧酸 |
105994-75-0 |
詳細(xì)
|
| Azacitidine Impurity 38 |
1-(4-氯苯基)吡唑-4-甲酸 |
138907-80-9 |
詳細(xì)
|
| Azacitidine Impurity 40 |
1-(4-甲氧基芐基)-1H-吡唑-4-羧酸 |
1105039-93-7 |
詳細(xì)
|
| 2-Chloro-4-(tert-pentyl)phenol |
618070-63-6 |
618070-63-6 |
詳細(xì)
|
| Cholesterol Impurity 20 |
1155065-29-4 |
1155065-29-4 |
詳細(xì)
|
| Salbutamol Impurity 76 |
乙基磺酰氯 |
594-44-5 |
詳細(xì)
|
| Cholesterol Impurity 24 |
531506-66-8 |
531506-66-8 |
詳細(xì)
|
| Brivaracetam Impurity 68 |
1-(3-BROMOPHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID |
959582-69-5 |
詳細(xì)
|
| Cholesterol Impurity 15 |
1,3-二苯基-1H-吡唑-4-羧酸 |
77169-12-1 |
詳細(xì)
|
| Cholesterol Impurity 14 |
1,3-DIMETHYL-5-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID |
861586-02-9 |
詳細(xì)
|
| Cholesterol Impurity 13 |
1-(4-甲氧基苯基)-5-甲基-1H-吡唑-4-酰肼 |
618092-46-9 |
詳細(xì)
|
| TAK438 Impurity 42 Monomer |
1-(4-氟苯)-5-甲基-1H-吡唑-4-酰肼 |
618092-48-1 |
詳細(xì)
|
| Cholesterol Impurity 22 |
1-[(3-氯苯基)甲基]-1H-吡唑-4-羧酸 |
1006494-84-3 |
詳細(xì)
|
| Cholesterol Impurity 23 |
1-[(3-甲基苯基)甲基]-1H-吡唑-4-羧酸 |
1006494-81-0 |
詳細(xì)
|
| Cholesterol Impurity 21 |
1,3,5-三甲基-1H-吡唑-4-甲酸 |
1125-29-7 |
詳細(xì)
|
| Ademetionine 1,4-Butanedisulfonate Impurity 19 |
// |
209960-58-7 |
詳細(xì)
|
| Trelagliptin Impurity 80 |
3-(4-甲氧基苯基)-1-苯基-1H-吡唑-4-羧酸 |
372107-36-3 |
詳細(xì)
|
| Bisphenol A Impurity 14 |
|
372490-42-1 |
詳細(xì)
|
| Drospirenone Impurity 13 |
屈螺酮雜質(zhì)13 |
1017781-26-8 |
詳細(xì)
|
| Cholesterol Impurity 17 |
|
60896-19-7 |
詳細(xì)
|